| 2019 | A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide
| 김건민, 김승일, 김주훈, 김지예, 김지형, 박세호, 박형석, 손주혁, 조영업 | Article |
| 2018 | Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's Perspective | 금기창, 김승일, 김용배, 김준원, 박세호, 박형석, 서창옥, 손주혁, 이익재, 정준, 최진현 | Article |
| 2018 | The Benefit of Pro Re Nata Antiemetics Provided With Guideline-Consistent Antiemetics in Delayed Nausea Control | 김건민, 김혜련, 라선영, 손주혁 | Article |
| 2018 | CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator
| 구자승, 김건민, 김승일, 박세호, 박형석, 손주혁 | Article |
| 2018 | Ramucirumab Safety in East Asian Patients: A Meta-Analysis of Six Global, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trials. | 손주혁, 정현철 | Article |
| 2018 | Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients
| 구자승, 김건민, 김민정, 김승일, 김은경, 문희정, 박병우, 박세호, 박영진, 손주혁, 윤정현, 조영업 | Article |
| 2018 | External validation of IBTR! 2.0 nomogram for prediction of ipsilateral breast tumor recurrence
| 구자승, 금기창, 김건민, 김용배, 김지예, 박세호, 박형석, 서창옥, 손주혁, 장지석, 조영업 | Article |
| 2017 | Meeting Highlights: The Second Consensus Conference for Breast Cancer Treatment in Korea
| 박세호, 손주혁, 안성귀, 이익재, 정준 | Article |
| 2017 | Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer | 김건민, 김승일, 박세호, 박형석, 박형순, 백순명, 손주혁, 정현철 | Article |
| 2017 | Chemotherapy-induced irreversible alopecia in early breast cancer patients | 김건민, 김도영, 김승일, 박세호, 박형석, 손주혁 | Article |
| 2017 | Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score-matched cohort study | 김승일, 박세호, 서다혜, 손주혁, 이유미, 홍남기 | Article |
| 2017 | Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer
| 김건민, 김승일, 손주혁, 안성귀, 유영훈, 윤미진, 이재훈, 이학우, 전태주, 정준 | Article |
| 2017 | An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer | 손주혁, 이수현 | Article |
| 2017 | Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR
| 김건민, 김승일, 박세호, 박형석, 손주혁 | Article |
| 2017 | Next-generation sequencing of BRCA1/2 in breast cancer patients: potential effects on clinical decision-making using rapid, high-accuracy genetic results
| 김건민, 김상화, 김승일, 김지예, 박세호, 박형석, 손주혁, 최종락, 황인식 | Article |
| 2016 | Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer
| 김승일, 손주혁 | Article |
| 2016 | Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy
| 김건민, 김승일, 김주훈, 박세호, 박형석, 손주혁, 허수진 | Article |
| 2016 | The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer.
| 손주혁 | Article |
| 2016 | Magnetic Resonance Imaging after Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate between No Residual Carcinoma and Residual Ductal Carcinoma In Situ in Patients with Triple-Negative Breast Cancer
| 김민정, 김승일, 김은경, 문희정, 박병우, 박세호, 박형석, 손주혁, 윤정현 | Article |
| 2016 | Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study
| 손주혁, 이수현 | Article |
| 2015 | Anaplastic lymphoma kinase gene copy number gain in inflammatory breast cancer (IBC): prevalence, clinicopathologic features and prognostic implication
| 구자승, 김민환, 김승일, 김주항, 박병우, 박세호, 박형석, 손주혁, 정준 | Article |
| 2015 | 성장인자수용체-2 양성 유방암 조직에서 표적치료 전후의 성장인자수용체군 발현양상
| 구자승, 김승일, 박병우, 박세호, 손주혁 | Article |
| 2015 | Do Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence?
| 금기창, 김승일, 김용배, 박병우, 서창옥, 손주혁, 이정심, 장지석, 정현철 | Article |
| 2015 | Detection of circulating tumor cell-specific markers in breast cancer patients using the quantitative RT-PCR assay | 김승일, 손주혁, 한현주 | Article |
| 2015 | Prediction of short- and long-term survival for advanced cancer patients after ICU admission | 김규리, 손주혁, 이수현, 이충근, 정경수, 최혜진, 허수진 | Article |
| 2014 | cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast Cancer
| 손주혁 | Article |
| 2014 | Patient-Reported Outcomes From EMILIA, a Randomized Phase 3 Study of Trastuzumab Emtansine (T-DM1) Versus Capecitabine and Lapatinib in Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced or Metastatic Breast Cancer | 손주혁 | Article |
| 2013 | Prolonged clinical benefit from the maintenance hormone therapy in patients with metastatic breast cancer | 김승일, 김주항, 박병우, 박세호, 손주혁, 이수현, 임승택, 최혜진, 한정우 | Article |
| 2013 | Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors
| 김주항, 김한상, 김효송, 노재경, 라선영, 손주혁, 신상준, 안중배, 이수현, 정현철, 조병철, 최혜진 | Article |
| 2013 | Functional proteomics characterization of residual triple-negative breast cancer after standard neoadjuvant chemotherapy
| 손주혁 | Article |
| 2013 | S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial
| 구자승, 김민정, 김승일, 김은경, 김주항, 박병우, 박세호, 손주혁, 이수현, 정현철 | Article |
| 2013 | A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer | 손주혁, 이수현 | Article |
| 2013 | Multicentre phase II trial of bevacizumab combined with docetaxel–carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905)
| 김승일, 김혜련, 손주혁, 이수현 | Article |
| 2012 | Prediction of outcomes for patients with brain parenchymal metastases from breast cancer (BC): a new BC-specific prognostic model and a nomogram
| 손주혁, 이수현 | Article |
| 2012 | Overexpression of class III beta tubulin and amplified HER2 gene predict good response to paclitaxel and trastuzumab therapy
| 구자승, 김승일, 김주항, 라선영, 문용화, 박병우, 박세호, 손주혁, 이수현, 정민규, 정현철, 홍수정 | Article |
| 2012 | Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial. | 손주혁 | Article |
| 2012 | Metaplastic breast cancer: clinicopathological features and its prognosis | 손주혁 | Article |
| 2011 | Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin | 김평환, 손주혁, 최정우 | Article |
| 2011 | Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen. | 강대용, 구자승, 문용화, 박병우, 박세호, 박형석, 손주혁, 정현철 | Article |
| 2011 | A phase I study of nimotuzumab in combination with radiotherapy in stages IIB-IV non-small cell lung cancer unsuitable for radical therapy: Korean results. | 권지은, 김세규, 김주항, 박무석, 손주혁, 심효섭, 양우익, 이익재, 이주희, 이창걸, 최혜진 | Article |
| 2011 | Continuous separation of breast cancer cells from blood samples using multi-orifice flow fractionation (MOFF) and dielectrophoresis (DEP). | 김승일, 손주혁 | Article |
| 2011 | Molecular Subtypes and Tumor Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer | 구자승, 김승일, 박병우, 박세호, 박형석, 손주혁 | Article |
| 2010 | Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer | 김귀언, 김주항, 손주혁, 이영주, 이창걸, 조병철, 최은창, 최혜진 | Article |
| 2010 | Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance | 구자승, 김승일, 김주항, 노재경, 문용화, 박병우, 박세호, 손주혁, 장현, 정현철, 최혜진 | Article |
| 2010 | Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: a phase II trial | 김세규, 김세현, 김주항, 박무석, 손주혁, 신상준, 장준, 정민규, 정재헌, 조병철, 최혜진 | Article |
| 2009 | Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC | 김세현, 김주항, 손주혁, 신상준, 유내춘, 조병철, 최혜진 | Article |
| 2009 | US surveillance of regional lymph node recurrence after breast cancer surgery. | 곽진영, 김민정, 김승일, 김은경, 문희정, 박병우, 손주혁, 육지현 | Article |
| 2009 | Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided versus empirical chemotherapy in unresectable non-small cell lung cancer
| 김세규, 김주항, 문용화, 손주혁, 이영주, 장준, 장현, 정민규, 정재헌, 홍수정 | Article |
| 2009 | Phase II study of transarterial holmium-166-chitosan complex treatment in patients with a single, large hepatocellular carcinoma | 김주항, 박경수, 손주혁, 유내춘, 이종두, 이종태, 최혜진 | Article |
| 2009 | Sonographic surveillance for the detection of contralateral metachronous breast cancer in an Asian population | 곽진영, 김민정, 김승일, 김은경, 박병우, 손주혁, 오기근 | Article |
http://orcid.org/0000-0002-2303-2764
(Yonsei Health Research Network)
(15045889800)
